Vegzelma 400 mg/16 mL (25 mg/mL) injection Images
Generic Name: bevacizumab
This medication has been identified as Vegzelma 400 mg/16 mL (25 mg/mL) injection. It is supplied by Celltrion, Inc.
Vegzelma is used in the treatment of Glioblastoma Multiforme; Colorectal Cancer; Fallopian Tube Cancer; Cervical Cancer; Non-Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Vegzelma 400 mg/16 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vegzelma
- Generic Name
- bevacizumab
- Strength
- 400 mg/16 mL (25 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celltrion, Inc.
- National Drug Code (NDC)
- 32228-0011
More about Vegzelma (bevacizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Vegzelma drug information
- Vegzelma (Bevacizumab Intravenous) (Advanced Reading)
- Vegzelma (Bevacizumab-adcd Intravenous) (Advanced Reading)
Other brands
Avastin, Mvasi, Zirabev, Alymsys, Avzivi
Professional resources
Other brands
Avastin, Mvasi, Zirabev, Alymsys
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
